Human Osteocytes Express MHC Class II and Act as Non-classical Antigen-Presenting Cells During Bacterial Infection
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Osteocytes are the most abundant cells in bone and are increasingly recognised not only for their role in skeletal remodelling and inflammatory signalling but also for their potential involvement in immune responses. In this study, we searched available gene expression datasets of human primary osteocyte-like cells exposed acutely to Staphylococcus aureus and identified significantly induced expression of key genes related to antigen processing and presentation. We then confirmed that human bone explant-derived osteoblastic cells, representative of a mature osteoblast-pre-osteocyte stage, expressed, as expected, high cell surface levels of major histocompatibility complex (MHC) Class I but also, low basal levels of the MHC Class II family member, HLA-DR. However, confocal imaging revealed high expression of MHC Class II molecules and the peptide-loading chaperone HLA-DM within the lysosomal compartments, consistent with canonical antigen-processing machinery. Differentiation towards a mature osteocyte phenotype increased MHC Class II protein levels and maintained expression of intracellular HLA-DM. Exposure of mature osteocyte-like cells to S. aureus further up-regulated both intracellular and cell surface MHC Class II expression. Demonstrative of antigen presenting cell functionality, S. aureus -exposed osteocytes induced autologous CD4 + T cell proliferation. Furthermore, MHC Class II expression in osteocytes was detected in bone sampled from patients with periprosthetic joint infections, providing evidence that these mechanisms operate in vivo . Together, our findings reveal that human osteocytes are capable of inducible MHC Class II-associated antigen presentation in response to bacterial challenge, pointing to a novel role for osteocytes in adaptive immune surveillance within bone.
Lay Summary
Osteocytes are the most common cell type in bone and are increasingly recognised as having important local and systemic regulatory functions. This study reveals a surprising new role: when challenged with bacteria, osteocytes can activate immune defence mechanisms normally associated with specialised immune cells. Specifically, human osteocytes express molecular signals that present to T cells, triggering a targeted immune response. We confirmed that this expression occurs in bone tissue taken from patients with infected joint replacements. These findings suggest that osteocytes play a key role in the immune response to bone infection, which may open new avenues for treating difficult-to-cure chronic bone infections.